(Q37958035)

25 August 2017

title

Treatment strategies for chronic stable angina (English)

1 reference

25 August 2017

author name string

Antonio Arrebola-Moreno

series ordinal

1

1 reference

25 August 2017

Jason Dungu

series ordinal

2

1 reference

25 August 2017

Juan-Carlos Kaski

series ordinal

3

1 reference

25 August 2017

language of work or name

English

0 references

publication date

1 December 2011

1 reference

Expert Opinion on Pharmacotherapy

25 August 2017

published in

1 reference

25 August 2017

volume

12

1 reference

25 August 2017

issue

18

1 reference

25 August 2017

page(s)

2833-2844

1 reference

Guidelines on the management of stable angina pectoris: executive summary: The Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology

25 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Pathophysiology and management of patients with chest pain and normal coronary arteriograms (cardiac syndrome X).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Coronary microvascular dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

21 January 2018

Mixed angina pectoris

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Compensatory enlargement of human atherosclerotic coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Coronary artery spasm and vasoconstriction. The case for a distinction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Angina pectoris and normal coronary arteries: cardiac syndrome X

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

21 January 2018

Endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

The pathophysiology of chronic ischemic heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Late sodium current inhibition as a new cardioprotective approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Intracellular Na+ regulation in cardiac myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Ionic basis of ischaemic cardiac injury: insights from cellular studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Cardiac KATP channels in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Inwardly rectifying potassium channels: their structure, function, and physiological roles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

2007 chronic angina focused update of the ACC/AHA 2002 guidelines for the management of patients with chronic stable angina: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Group to

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Predicting prognosis in stable angina--results from the Euro heart survey of stable angina: prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

B-type natriuretic peptides: prognostic markers in stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

The human costs of tobacco use (1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Comparison of low-fat versus Mediterranean-style dietary intervention after first myocardial infarction (from The Heart Institute of Spokane Diet Intervention and Evaluation Trial).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Accumulated evidence on fish consumption and coronary heart disease mortality: a meta-analysis of cohort studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Meta-analysis of wine and beer consumption in relation to vascular risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Differential effects of antihypertensive drugs on neurohormonal activation: insights from a population-based sample

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Nebivolol: haemodynamic effects and clinical significance of combined beta-blockade and nitric oxide release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Effect of nebivolol on blood oxygen transport indices and endothelial dysfunction in patients with arterial hypertension.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Nitrates and nitrites in the treatment of ischemic cardiac disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Recent findings on nitrates: their action, bioactivation and development of tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

The antianginal drug trimetazidine shifts cardiac energy metabolism from fatty acid oxidation to glucose oxidation by inhibiting mitochondrial long-chain 3-ketoacyl coenzyme A thiolase

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Trimetazidine in Angina Combination Therapy--the TACT study: trimetazidine versus conventional treatment in patients with stable angina pectoris in a randomized, placebo-controlled, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Efficacy of ivabradine, a new selective I(f) inhibitor, compared with atenolol in patients with chronic stable angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Efficacy of ivabradine, a selective I(f) inhibitor, in patients with chronic stable angina pectoris and diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Effect of nicorandil on coronary events in patients with stable angina: the Impact Of Nicorandil in Angina (IONA) randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Anti-ischemic effects and long-term survival during ranolazine monotherapy in patients with chronic severe angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Evaluation of the glycometabolic effects of ranolazine in patients with and without diabetes mellitus in the MERLIN-TIMI 36 randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Telmisartan, ramipril, or both in patients at high risk for vascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Effects of antihypertensive treatment on ultrasound measures of myocardial fibrosis in hypertensive patients with left ventricular hypertrophy: results of a randomized trial comparing the angiotensin receptor antagonist, candesartan and the angioten

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Expanding the orbit of primary prevention--moving beyond JUPITER.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

The ASTEROID trial: coronary plaque regression with high-dose statin therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Experience with revascularization procedures does matter: low volume means worse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Management of stable coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

The impact of revascularization on mortality in patients with nonacute coronary artery disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Optimal medical therapy with or without PCI for stable coronary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

A randomized trial of therapies for type 2 diabetes and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Value of the SYNTAX score in patients treated by primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: The MI SYNTAXscore study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Factors influencing underutilization of evidence-based therapies in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Women and ischemic heart disease: evolving knowledge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Gender differences in the treatment of chronic ischemic heart disease: prognostic implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

Meta-analysis of Trials Comparing β-Blockers, Calcium Antagonists, and Nitrates for Stable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656566.2011.634799

10.1517/14656566.2011.634799

21 January 2018

Identifiers

DOI

1 reference

25 August 2017

1 reference